INDERAL-LA 160 MG
PROPRANOLOL HYDROCHLORIDE : 160 MG · DIN 02042274 · PFIZER CANADA ULC
Health Canada status: CANCELLED POST MARKET
What is INDERAL-LA?
INDERAL-LA 160 MG contains PROPRANOLOL HYDROCHLORIDE : 160 MG. It is listed in the Health Canada Drug Product Database under DIN 02042274, held by PFIZER CANADA ULC, supplied as CAPSULE (EXTENDED RELEASE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 31-May-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is INDERAL-LA used for?
INDERAL-LA (propranolol hydrochloride extended-release capsules, USP) is indicated for: maintenance therapy in the treatment of hypertension; prophylaxis of angina pectoris. As with conventional propranolol hydrochloride tablets, INDERAL-LA capsules are compatible with thiazide-like diuretics and/or peripheral vasodilators. Combinations of INDERAL-LA with thiazide-like diuretics and/or peripheral vasodilators have been shown to be generally more effective than INDERAL-LA alone.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02042274 |
|---|---|
| Brand name | INDERAL-LA |
| Generic / active ingredient | PROPRANOLOL HYDROCHLORIDE : 160 MG |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 160 MG |
| Dosage form | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C07AA05 PROPRANOLOL |
| AHFS class | 24:24.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 31-May-2022 |
| Original market date | 1994-12-31 00:00:00 |
How is it stored and handled?
null
How is it supplied?
Bottles of 100 capsules.
What can be used instead?
Other Canadian products sharing ATC code C07AA05 PROPRANOLOL. 13 of 56 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| HEMANGIOL | 3.75 MG | SOLUTION | PIERRE FABRE DERMO-COSMETIQUE CANADA INC | MARKETED | DIN 02457857 |
| LUPIN-PROPRANOLOL LA | 120 MG | CAPSULE (EXTENDED RELEASE) | LUPIN PHARMA CANADA LIMITED | MARKETED | DIN 02491915 |
| LUPIN-PROPRANOLOL LA | 160 MG | CAPSULE (EXTENDED RELEASE) | LUPIN PHARMA CANADA LIMITED | MARKETED | DIN 02491923 |
| LUPIN-PROPRANOLOL LA | 60 MG | CAPSULE (EXTENDED RELEASE) | LUPIN PHARMA CANADA LIMITED | MARKETED | DIN 02491893 |
| LUPIN-PROPRANOLOL LA | 80 MG | CAPSULE (EXTENDED RELEASE) | LUPIN PHARMA CANADA LIMITED | MARKETED | DIN 02491907 |
| PROPRANOLOL HYDROCHLORIDE INJECTION USP | 1 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02225883 |
| PRZ-PROPRANOLOL | 20 MG | TABLET | PHARMARIS CANADA INC | MARKETED | DIN 02550814 |
| PRZ-PROPRANOLOL | 40 MG | TABLET | PHARMARIS CANADA INC | MARKETED | DIN 02550822 |
| PRZ-PROPRANOLOL | 80 MG | TABLET | PHARMARIS CANADA INC | MARKETED | DIN 02550830 |
| TEVA-PROPRANOLOL | 10 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 00496480 |
Who else supplies PROPRANOLOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PROPRANOLOL appears in 157 registered pack listings across 14 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.